Velarion Records
Free. Unsubscribe any time.

Protagonist Therapeutics, Inc (PTGX)

Protagonist Therapeutics, Inc filed 10 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 14 transactions and 351,000 shares. None carries the SEC's AFF10B5ONE flag; all 10 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Protagonist Therapeutics, Inc 14

Adoption dates in Protagonist Therapeutics, Inc 3

Results prints in Protagonist Therapeutics, Inc 7

Trades before a print in Protagonist Therapeutics, Inc 0

Interval to Protagonist Therapeutics, Inc’s next reported results date

How the interval and sources are counted →

Adoption dates Protagonist Therapeutics, Inc states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on November 10, 2023”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.